TRANSVAC2, an European vaccine research and development (R&D) infrastructure project, is dedicated to accelerating the development of safe, effective and affordable vaccines. Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at a single organization.
TRANSVAC2 also offers free training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics, centralising and expanding the training opportunities available to the European vaccine community. There is an open call for the following free training modules until December 15th:
M3: Adjuvants and Vaccine Formulations – offered by Vaccine Formulation Institute (VFI)
M5: Statistics of vaccine evaluation – offered by Biomedical Primate Research Centre (BPRC)
M14: Regulatory aspects of vaccine development, – offered by European Infrastructure for Translational Medicine (EATRIS)
More info HERE.